2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice.
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_C0B82DDF6898
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice.
Périodique
Annals of the rheumatic diseases
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Statut éditorial
Publié
Date de publication
15/05/2024
Peer-reviewed
Oui
Volume
83
Numéro
6
Pages
752-759
Langue
anglais
Notes
Publication types: Journal Article ; Practice Guideline
Publication Status: epublish
Publication Status: epublish
Résumé
To formulate evidence-based recommendations and overarching principles on the use of imaging in the clinical management of crystal-induced arthropathies (CiAs).
An international task force of 25 rheumatologists, radiologists, methodologists, healthcare professionals and patient research partners from 11 countries was formed according to the EULAR standard operating procedures. Fourteen key questions on the role of imaging in the most common forms of CiA were generated. The CiA assessed included gout, calcium pyrophosphate deposition disease and basic calcium phosphate deposition disease. Imaging modalities included conventional radiography, ultrasound, CT and MRI. Experts applied research evidence obtained from four systematic literature reviews using MEDLINE, EMBASE and CENTRAL. Task force members provided level of agreement (LoA) anonymously by using a Numerical Rating Scale from 0 to 10.
Five overarching principles and 10 recommendations were developed encompassing the role of imaging in various aspects of patient management: making a diagnosis of CiA, monitoring inflammation and damage, predicting outcome, response to treatment, guided interventions and patient education. Overall, the LoA for the recommendations was high (8.46-9.92).
These are the first recommendations that encompass the major forms of CiA and guide the use of common imaging modalities in this disease group in clinical practice.
An international task force of 25 rheumatologists, radiologists, methodologists, healthcare professionals and patient research partners from 11 countries was formed according to the EULAR standard operating procedures. Fourteen key questions on the role of imaging in the most common forms of CiA were generated. The CiA assessed included gout, calcium pyrophosphate deposition disease and basic calcium phosphate deposition disease. Imaging modalities included conventional radiography, ultrasound, CT and MRI. Experts applied research evidence obtained from four systematic literature reviews using MEDLINE, EMBASE and CENTRAL. Task force members provided level of agreement (LoA) anonymously by using a Numerical Rating Scale from 0 to 10.
Five overarching principles and 10 recommendations were developed encompassing the role of imaging in various aspects of patient management: making a diagnosis of CiA, monitoring inflammation and damage, predicting outcome, response to treatment, guided interventions and patient education. Overall, the LoA for the recommendations was high (8.46-9.92).
These are the first recommendations that encompass the major forms of CiA and guide the use of common imaging modalities in this disease group in clinical practice.
Mots-clé
Humans, Crystal Arthropathies/diagnostic imaging, Ultrasonography/methods, Chondrocalcinosis/diagnostic imaging, Gout/diagnostic imaging, Gout/drug therapy, Magnetic Resonance Imaging/methods, Tomography, X-Ray Computed, Evidence-Based Medicine, Radiography, Crystal arthropathies, Magnetic Resonance Imaging, Ultrasonography
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/02/2024 11:35
Dernière modification de la notice
17/05/2024 7:15